Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
4
Filing Date
11/18/2025
Updated
11/19/25, 2:05 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership